Pharma M&A versus alliances and its underlying value drivers - Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective

Name: Pharma M&A versus alliances and its underlying value drivers
Price: 46.7 EUR
Availability: Instock
Author: Heiko Schön
ISBN: 9783631663813

Heiko Schön

Note moyenne

Donner le premier avis

Heiko Schön - Pharma M&A versus alliances and its underlying value drivers - Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective.

From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between... Lire la suite

46,70 € Neuf

Expédié sous 2 à 4 semaines

Livré chez vous entre le 10 mai et le 24 mai

En librairie

From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story ? The author derives significant innovative determinants of success for both strategies.

Date de parution

01/09/2015
Editeur

Peter Lang
Collection

Corporate Finance and Governan
ISBN

978-3-631-66381-3
EAN

9783631663813
Nb. de pages

201 pages

Écoutez ce qu'en disent nos libraires !

Biographie de Heiko Schön

Heiko Schön studied international business administration at Wiesbaden Business School. He was scholar of the German National Merit Foundation (sdw), he owns an Executive MBA from the University of Münster and earned his PhD at the University of Darmstadt. He brings in 10 years of experience in the pharmaceutical and chemical industry.